Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone MetastasesGregory C. Fox, Katherine N. Weilbaecher, Xinming Su et al.|Molecular Cancer Therapeutics|2021Cited by 23
Supplementary Methods from Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone MetastasesGregory C. Fox, Katherine N. Weilbaecher, Xinming Su et al.|Unknown|2023Cited by 0
Supplementary Figure S6 from Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone MetastasesGregory C. Fox, Katherine N. Weilbaecher, Xinming Su et al.|Unknown|2023Cited by 0
Supplementary Figure S4 from Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone MetastasesGregory C. Fox, Katherine N. Weilbaecher, Xinming Su et al.|Unknown|2023Cited by 0
Supplementary Methods from Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone MetastasesGregory C. Fox, Katherine N. Weilbaecher, Xinming Su et al.|Unknown|2023Cited by 0